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Background: Oropharyngeal squamous cell carcinoma (OSCC) has shown a gradual increase in male predominance
due to the increasing incidence of human papillomavirus (HPV)-associated OSCC. However, the mode of HPV
transmission to the oral cavity is poorly understood, and little is known about the epidemiology of oral HPV infection in
men. The prevalence rates of HPV, Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp.
were compared in the oropharynx (oral cavity) and urine of male Japanese patients attending a sexually transmitted
disease clinic.
Methods: The study population consisted of 213 men aged 16 – 70 years old (mean: 34.4 years old). Oropharyngeal
gargles and urine were collected, and sedimented cells were preserved in liquid-based cytology solution. After DNA
extraction, β-globin and infectious organisms were analyzed by a PCR-based method. The HPV genotype was
determined by HPV GenoArray test.
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Results: β-Globin was positive in 100% and 97.7% of oral and urine samples, respectively. HPV detection rates were
18.8% and 22.1% in oral and urine samples, respectively, suggesting that the prevalence of HPV infection in the oral
cavity was similar to that in the urinary tract. N. gonorrhoeae was more prevalent in oral (15.6%) than urine samples
(9.1%), whereas C. trachomatis was detected more frequently in urine (15.9%) than oral samples (4.2%). The detection
rates of M. genitalium, M. hominis, and Ureaplasma spp. were 5.2%, 10.3%, and 16.0% in oral samples, and 7.7%, 6.3%,
and 19.2% in urine, respectively. There were no significant differences in the detection rates of Mycoplasma spp. and
Ureaplasma spp. between anatomical locations. The distribution of HPV types were similar in oral and urine samples,
and HPV16 was the most common type. The majority of men with HPV infection in both the oral cavity and urine had
concordant oral and urinary HPV infection. The presence of urinary HPV infection was an independent risk factor of oral
HPV infection, with an odds ratio of 3.39 (95% CI: 1.49 – 7.71), whereas oral gonococcal infection was inversely
correlated with oral HPV infection (odds ratio: 0.096; 95% CI: 0.01 – 0.77).
Conclusions: Oral HPV infection commonly occurs in sexually active men, and is significantly correlated with urinary
HPV infection.
Keywords: Human papillomavirus, Oral infection, Mycoplasma, Ureaplasma, Liquid-based cytologyBackground
Human papillomavirus (HPV) infection is a necessary
element for the development of virtually all cases of cer-
vical cancer in women [1], and has also been identified
as a risk factor for the development of anal, penile, and
oropharyngeal cancers [2-4]. In particular, oropharyngeal
squamous cell carcinoma (OSCC) has shown a gradual
increase in male predominance since the 1970s, despite
reductions in smoking, as a result of the increasing inci-
dence of HPV-associated OSCC. Indeed, a recent study
indicated that HPV detection represented about 70% of
all OSCCs in the USA in 2007, compared with 10% in
the 1980s [5], and another large-scale study indicated
that the HPV prevalence of 323 OSCC cases was 63.8%
(206 cases) [6]. A Japanese epidemiological report in
2008 by the Ministry of Health, Labour and Welfare
found that the incidence of OSCC has also been grad-
ually increasing over the last three decades in Japan,
which is likely due to the increase in HPV-positive cases
[7]. HPV-associated OSCC is now a well-defined entity
with well-known characteristics that include young age,
good performance status, male gender, nonsmoking, and
high-risk sexual behavior [6,8].
Cervical HPV infection appears to occur frequently
within a few years of sexual debut, and its prevalence
decreases with increasing age from the peak preva-
lence in younger women [9]. Sexually transmitted cer-
vical HPV infection, when it persists for 10 – 15 years,
presents a risk of developing precancerous lesions of
the cervix, which can progress to invasive cervical
cancer. On the other hand, HPV-associated OSCC is
also thought to be induced by oropharyngeal HPV
infection. However, the mode of transmission of HPV to
the oral cavity is less well understood, and little is known
about the epidemiology of oral pharyngeal HPV infection
in men.In the present study, we investigated the prevalence of
HPV infection and HPV types in the oropharynx (oral
cavity) and urine of male Japanese patients who attended
a sexually transmitted disease (STD) outpatient clinic,
and the concordance of infected HPV types between
these two infection sites. In addition, the infection sta-
tuses of Neisseria gonorrhoeae, Chlamydia trachomatis,
Mycoplasma spp., and Ureaplasma spp. were also exam-
ined in oral and urine samples, and we investigated the




A total of 213 male Japanese patients who attended the
STD outpatient clinic of Kanazawa University Hospital
(Kanazawa, Japan), Ishikawa Prefectural Central Hospital
(Kanazawa, Japan), Dokkyo Medical School, Koshigaya
Hospital (Koshigaya, Japan), Wakatsuki Clinic (Osaka,
Japan), and Nakashima Clinic (Kanazawa, Japan) were
enrolled in this study. All participants were men who
had sex with women, and homosexual or bisexual men
were excluded from the study. The ethics committee of
Kanazawa University Graduate School of Medicine ap-
proved this study. Oropharyngeal gargle and urine sam-
ples were obtained from each subject after obtaining
their written informed consent. A clinical diagnosis of
urethritis was defined as ≥ 5 polymorphonuclear leuko-
cytes per high-power field in collected urethral swabs.
To obtain oral specimens, each subject swished 15 mL
of normal saline around their oral cavity, gargled with
their head tilted back for 10 – 20 s, and then expecto-
rated into a specimen cup. In addition, all urine from
one urination for each patient was collected in an indi-
vidual urine cup, and 15 mL was placed into a sep-
arate tube. Each sample (15 mL) was centrifuged at
Table 1 Patient backgrounds (n = 213)
Variables n
Mean age (range) 34.3 (16 – 70)
Number of patients with urethritis 91 (43%)
Gonococcal 17
Chlamydial 31
Gonococcal and chlamydial 2
Non-gonococcal and non-chlamydial 41
Number of patients non-urethritis 122 (57%)
Herpes genitalis 2
Asymptomatic Trichomonas infection 1
Asymptomatic (for STD check) 119
STD, sexually transmitted disease.
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placed into a separate tube containing 2.5 mL of preserva-
tive solution for liquid-based cytology (LiquiPrep; LGM
International Inc., Melbourne, FL, USA) and stored at 4°C
until use.
HPV-DNA test and genotyping
Aliquots of 800 μL of preservative solution containing
cell samples were centrifuged at approximately 1500 × g
for 10 min, and the supernatants were discarded. The
cell pellets were washed twice with 300 μL of 10 mmol/L
Tris-HCl (pH 8.0). DNA was extracted from the cells
using a DNA extraction kit (SMI Test; G&G Science
Co., Fukushima, Japan) according to the manufacturer’s
instructions. The β-globin gene was first amplified to
confirm the adequacy of the extracted DNA in all samples.
In β-globin-positive samples, HPV-DNA was tested by
modified GP5+/GP6+ polymerase chain reaction (PCR) as
described previously [10].
HPV genotyping was performed using HPV GenoArray
Test Kits (HybriBio Limited, Chaozhou, China) according
to the manufacturer’s protocol. This assay can be used to
determine 21 HPV genotypes, consisting of 14 high-risk
HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66,
and 68), 5 low-risk HPV types (6, 11, 42, 43, and 44), and
two unknown-risk types (53 and CP8304), by flow-through
hybridization using HPV-DNA amplified by PCR [11]. In-
ternal control and HPV genotype were visualized simultan-
eously as spots at the position of control and each HPV
type probe on the same membranes [11]. This is a kit that
has recently become commercially available, and has
shown good agreement (93.8%) in detection of HPV types
with the results of the Amplicor HPV test, as described
previously [12].
Detection of N. gonorrhoeae, C. trachomatis, M. genitalium,
M. hominis, and Ureaplasma spp. (biovars 1 and 2)
N. gonorrhoeae was detected in each liquid-based sample
by PCR using specific primers targeting the N. gonor-
rhoeae orf1 gene [13]. For the 427 urethral swabs, the
sensitivity, specificity, positive predictive value, negative
predictive value for this PCR method were reported to be
100%, 98%, 99.7%, and 100%, respectively. The primer for
C. trachomatis amplified a 205-bp fragment of the 16S
rRNA gene, as described previously, and had sensitivity
and specificity of 97.9% and 98.7%, respectively [14].
Mycoplasma genitalium, Mycoplasma hominis, and
Ureaplasma spp. (biovars 1 and 2) were detected by
multiplex PCR assay as described by Stellrecht et al.
[15,16]. This Multiplex PCR is a simple and convenient
method performed with primers specific for highly con-
served regions in the urease gene of Ureaplasma spp.,
the 140-kDa adhesion protein gene of M. genitalium, and
the 16S rRNA gene of M. hominis, yielding bands of403 – 448 bp, 282 bp, and 334 bp, respectively [16]. The
overall sensitivity, specificity, and positive and negative
predictive values of multiplex PCR analyses for detection
of Mycoplasma spp. and Ureaplasma spp. were 87%,
96%, 94%, and 93%, respectively, with an analytical lower
limit of detection of < 12.5 colony forming units (cfu) for
Ureaplasma spp., M. genitalium, and M. hominis, even if
these organisms were mixed together.
Statistical analysis
The chi-square test was used to compare HPV-positive
rates between the two anatomical sites among all 213
patients. Univariate and multivariate analysis using un-
conditional direct logistic regression analysis for all vari-
ables was performed to determine the risk factors for
detection of oral HPV infection, and the odds ratios
(OR) and 95% confidence intervals (CI) were calculated.
The SPSS statistical software package (version 17.0; SPSS
Inc., Chicago, IL) was used for all analyses, and P < 0.05
was taken to indicate statistical significance.
Results
Among the 213 participants aged 16 – 70 years (mean ± SD;
34.3 ± 10.2 years), 91 (43%) had urethritis, comprised of
17 gonococcal, 31 chlamydial, 2 gonococcal and chlamyd-
ial, and 41 non-gonococcal and non-chlamydial infections
(Table 1). The other 122 patients had no evidence of ur-
ethritis. Among these 122 patients, two with painful clus-
ters of genital sores consisting of vesicles on the penile
surface were diagnosed as having Herpes genitalis, and
Trichomonas was incidentally identified in one patient
based on urinary microscopic examination. There were
no patients with any pharyngitis-like symptoms.
Positive amplification of the β-globin gene was ob-
served in all 213 (100%) of the oral samples and in 208
(97.7%) of the urine samples (Table 2). Among the β-
globin-positive samples, the HPV detection rates were
18.8% in oral samples and 22.1% in urine samples. High-
Table 2 Results of PCR analysis of oral samples and urine
samples by liquid-based cytology
Oral cavity Urine P-value
(n = 213) (n = 213)
Number of adequate samples (%) 213 (100%) 208 (97.7%)
HPV detection rate (%) 40 (18.8%) 46 (22.1%) 0.331
High-risk HPV detection rate (%) 30 (14.1%) 32 (15.4%) 0.575
Low-risk HPV detection rate (%) 12 (5.6%) 19 (9.1%) 0.276
Frequency of single-type HPV
infection (%)
30 (75.0%) 24 (52.2%) 0.029
N. gonorrhoeae (%) 36 (15.6%) 19 (9.1%) 0.018
C. trachomatis (%) 9 (4.2%) 33 (15.9%) < 0.001
M. genitalium (%) 11 (5.2%) 16 (7.7%) 0.290
M. hominis (%) 22 (10.3%) 13 (6.3%) 0.130
Ureaplasma spp. (%) 34 (16.0%) 40 (19.2%) 0.378
PCR, polymerase chain reaction; HPV, human papillomavirus.
Table 3 Type-specific prevalence rates of HPV in oral and
urine samples
HPV type Oral cavity (n = 40) Urine (n = 46)
n (%) n (%)
High-risk type
16 17 (42.5) 19 (41.3)
18 7 (17.5) 11 (23.9)
33 5 (12.5) 6 (13.0)
39 - 1 (2.2)
52 1 (2.5) 3 (6.5)
53 - 2 (4.3)
58 1 (2.5) 3 (6.5)
59 1 (2.5) 2 (4.3)
66 - 1 (2.2)
Low-risk type
6 8 (20.0) 11 (23.9)
11 5 (12.5) 10 (21.7)
Unknown type
1 (2.5) 2 (4.3)
HPV, human papillomavirus.
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15.4% of urine samples. There were no significant differ-
ences in the prevalence raters of HPV or high-risk HPV
between oral and urine samples. N. gonorrhoeae was
more prevalent in oral samples (15.6%) than in urine
samples (9.1%), whereas C. trachomatis was detected more
frequently in urine samples (15.9%) than in those from the
oral cavity (4.2%). On the other hand, the detection rates
of M. genitalium, M. hominis, and Ureaplasma spp. were
5.2%, 10.3%, and 16.0% in the oral cavity and 7.7%, 6.3%,
and 19.2% in urine, respectively. The differences in
detection rates between oral and urine samples were not
significant.
The HPV type distributions were similar in oral and
urinary samples, and HPV16 was the most common type,
followed by types 6, 18, 11, and 33 (Table 3). However,
single-type HPV infection was frequently identified in the
oral cavity (30/40 cases; 75.0%), whereas multiple-type
HPV infection was found more frequently in urine samples
than in oral samples (Table 2). Moreover, there were 18
cases with HPV infection at both anatomical sites (Table 4).
Among these cases, the detected HPV types in oral and
urinary samples were in complete agreement in 8 cases
(44.4%), and were consistently similar in 16 cases (88.9%).
In addition, we attempted to identify the risk factors
for oral HPV infection. Multivariate analysis indicated
that the presence of urinary HPV infection was an inde-
pendent risk factor for oral HPV infection, with an odds
ratio of 3.39 (95% CI: 1.49 – 7.71) (Table 5). Moreover,
oral gonococcal infection was inversely correlated with oral
HPV infection (odds ratio: 0.096; 95% CI: 0.01 – 0.77). On
the other hand, age, presence of urethritis, and coinfection
of the urinary tract with C. trachomatis, M. genitalium,
M. hominis, Ureaplasma spp., and N. gonorrhoeae were
not correlated with oral HPV infection.Discussion
There is substantial molecular evidence suggesting a role
for HPV infection in the pathogenesis of OSCC, and the
incidence of HPV-associated OSCC has been gradually
increasing worldwide [5,6]. The development of oral
HPV infection is essential in the first phase of the devel-
opment of HPV-associated OSCC, and oral sexual inter-
course is suspected to be a route of oral HPV infection.
Indeed, a case-control study of HPV and OSCC demon-
strated that oral HPV infection is strongly associated
with OSCC, and indicated that a high lifetime number
of oral sex partners (more than 6 partners) was an inde-
pendent risk factor for OSCC, with an odds ratio of 3.4
(95% CI: 1.3 – 8.8) [17]. However, little information is
available regarding the epidemiological status of oral
HPV infection, especially in men. Thus, the prevalence of
HPV infection in the oropharynx (oral cavity) and urine in
men was examined in the present study. We found that
the prevalence rates of HPV infection among Japanese
men who attended an STD clinic were 18.8% and 22.1% in
oral and urine samples, respectively. This is the first study
to compare the HPV detection rate of the oral cavity and
urine, and the HPV detection rate in the oral cavity was
similar to that in urine among these subjects.
D'Souza et al. investigated the prevalence of oropha-
ryngeal HPV infection using mouthwash among 332
control patients who attended an outpatient otolaryngol-
ogy clinic and 210 college-age men in the USA [18]. HPV
infection was detected in 4.8% of 332 control patients from
the outpatient clinic and in 2.9% of 210 college-age men,
Table 4 Details of HPV types in cases in which HPV was
detected from both oral and urine samples
Oral cavity Urine
Case 1 16 16, 52
Case 2 16 16, 18
Case 3 16, 33 11, 16, 33
Case 4 16, 33 33
Case 5 16, 33 16, 33
Case 6 18 18
Case 7 18 18
Case 8 6 18
Case 9 6, 16 6
Case 10 16 16, 53
Case 11 16 6, 16
Case 12 6 6
Case 13 16 16
Case 14 16 16
Case 15 16 16
Case 16 6, 11 11
Case 17 18 11
Case 18 18 18
HPV was detected in both oral and urine samples from 16 cases.
HPV, human papillomavirus.
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open-mouth kissing partners were found to be risk factors
for oral HPV infection. Kreimer et al. detected oral HPV
infection in 4.0% (67 cases) of 1608 healthy men aged
18 – 78 from the USA, Mexico, and Brazil using the Roche
linear array HPV genotyping assay [19]. In addition, a re-
cent systematic review indicated that 1.3% of 3977 healthy
subjects had oral HPV16, 3.5% of 4441 subjects had high-
risk HPV, and 4.5% of 4070 subjects were positive for any
HPV. Men and women had similar prevalence rates of
any oral HPV (4.6% and 4.4%, respectively) [20]. These
previous reports suggest that the oropharyngeal HPV
prevalence rate among healthy subjects is approximately
3% – 4%, and that HPV is rarely detected in oral speci-
mens compared with genital or urine samples from
healthy individuals.
However, the prevalence in our subjects (18.8%) was
much higher compared with those reported in previous
studies, which was likely due to the difference in study
populations. Our study was performed in male patients
who attended an STD clinic, and therefore they repre-
sented a population that would have risk factors for
sexually transmitted infection. Indeed, the prevalence of
oral HPV infection in women was also reported to differ
according to the study population, and its prevalence
was higher (23.6%) in women who attended STD out-
patient clinics [21] compared with healthy women [22,23].In addition, a cohort study of 212 men aged 18 – 24 indi-
cated that nearly 20% of sexually active male university
students had evidence of oral HPV infection within 12
months [24]. Moreover, the HPV prevalence rate in oral
samples among our subjects was approximately equivalent
to that in urine samples, which is a common HPV detec-
tion site in sexual active men [11,25]. Oral HPV infection
may also be a sexually transmitted infection similar to
genital HPV infection. However, in the present study there
was a lack of data regarding the ways and frequencies of
sexual contact or number of sexual partners in our popula-
tion. Further epidemiological studies including such sexual
information and healthy controls are required to reach
more definitive conclusions.
We found that type-specific HPV prevalence was simi-
lar in oral and urinary samples, and HPV16 was the
most common type identified in the present study. In
addition, the majority of men with HPV infection in
both the oral cavity and urine specimens had concordant
oral and urinary HPV infection, suggesting that oral
HPV infection in men may also occur through oral and
genital contact with women. Indeed, the present study
demonstrated that the presence of urinary HPV infec-
tion is an independent risk factor for oral HPV infection,
with an odds ratio of 3.39.
Moreover, single-type HPV infection was frequently
identified in the oral cavity, and single HPV16 was the
most common type. Many epidemiologic studies indi-
cated that HPV16 is the most common HPV type de-
tected from HPV-associated OSCC [17,18], which is
consistent with our findings. Multiple-type HPV infec-
tion is commonly observed in the cervix of women, low-
grade cervical intraneoplasia (CIN), and male external
genitalia. On the other hand, single-type HPV infection
is an indicator of high-grade CIN or cervical cancer [26].
Although this difference between oral and urinary HPV
infection has not been clarified, the oral cavity in men
may be easily infected by HPV16. Alternatively, HPV16
infection may be persistent in the oral cavity in men.
However, further studies of the natural history of oral HPV
infection in men are required to confirm this hypothesis.
We performed another additional study to investigate
the possible associations between oral HPV infection
and other organisms responsible for sexually transmitted
infections (STIs). In a previous study, we investigated the
prevalence rates of Mycoplasma spp. and Ureaplasma
spp. using liquid-based cytology samples of urine [25].
M. genitalium, M. hominis, Ureaplasma parvum, and
Ureaplasma urealyticum were detected in 14.5%, 10.9%,
6.5%, and 12.3% of men with urethritis, whereas these
species were detected in 3.3%, 2.0%, 4.7%, and 2.7% of
controls, respectively [25]. Takahashi et al. also reported
prevalence rates of 1%, 4%, 12%, and 23% for M. gen-
italium, M. hominis, U. parvum, and U. urealyticum,
Table 5 Univariate and multivariate analyses of risk factors for detection of any HPV infection in oral samples
n
Oral HPV infection Univariate analysis Multivariate analysis
Variables Positive Negative Odds ratio 95% CI P Odds ratio 95% CI P
Age (yo)
< 35 115 23 92 1.0 (referent) 1.0 (referent)
≥ 35 98 17 81 0.65 0.12–1.70 0.647 0.71 0.32–1.58 0.402
Urine HPV infection
negative 167 22 145 1.0 (referent) 1.0 (referent)
positive 46 18 28 4.24 2.02–8.91 <0.001 3.39 1.49–7.71 0.004
Urethritis
negative 122 28 94 1.0 (referent) 1.0 (referent)
positive 91 12 79 0.51 0.24–1.07 0.0711 0.78 0.32–1.81 0.532
Oral samples
N. gonorrhoeae: negative 177 38 139 1.0 (referent) 1.0 (referent)
positive 36 2 34 0.22 0.05–0.94 0.016 0.096 0.01–0.77 0.027
C. trachomatis: negative 204 39 165 1.0 (referent) 1.0 (referent)
positive 9 1 8 0.53 0.06–4.35 0.470 0.39 0.03–4.69 0.460
M. genitalium: negative 202 39 163 1.0 (referent) 1.0 (referent)
positive 11 1 10 0.42 0.05–3.36 0.353 0.28 0.02–3.10 0.296
M. hominis: negative 191 35 156 1.0 (referent) 1.0 (referent)
positive 22 5 17 1.31 0.45–3.79 0.398 0.68 0.10–4.50 0.692
Ureaplasma: negative 179 33 146 1.0 (referent) 1.0 (referent)
positive 34 7 27 1.15 0.46–2.86 0.464 0.52 0.09–3.16 0.478
Any organisms: negative 126 26 100 1.0 (referent) 1.0 (referent)
positive 87 14 73 0.74 0.36–1.51 0.405 3.84 0.59–27.92 0.184
Urine samples
N. gonorrhoeae: negative 194 38 156 1.0 (referent) 1.0 (referent)
positive 19 2 17 0.48 0.11–2.18 0.267 0.56 0.04–7.62 0.663
C. trachomatis: negative 180 38 142 1.0 (referent) 1.0 (referent)
positive 33 2 31 0.24 0.06–1.05 0.051 0.21 0.02–2.10 0.186
M. genitalium: negative 197 39 158 1.0 (referent) 1.0 (referent)
positive 16 1 15 0.27 0.04–2.11 0.158 0.64 0.05–8.77 0.737
M. hominis: negative 200 38 162 1.0 (referent) 1.0 (referent)
positive 13 2 11 0.78 0.17–3.64 0.545 0.42 0.06–2.96 0.380
Ureaplasma: negative 173 31 142 1.0 (referent) 1.0 (referent)
positive 40 9 31 1.33 0.58–3.07 0.320 1.29 0.12–10.60 0.814
Any organisms: negative 116 26 90 1.0 (referent) 1.0 (referent)
positive 97 14 83 0.58 029–1.19 0.140 0.94 0.09–9.43 0.958
HPV, human papillomavirus.
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healthy Japanese men [27]. These findings are different
from the present results. In particular, M. genitalium has
been widely accepted as an agent of STIs, and the differ-
ences between these studies may have been due to differ-
ences in the sample size and characteristics of the study
populations as well as the detection methods used. On theother hand, little information is available regarding the
prevalence rates of Mycoplasma spp. and Ureaplasma spp.
in the male oral cavity. Sackel et al. reported that M. homi-
nis and Ureaplasma spp. were recovered from pharyngeal
samples obtained from 149 (14.3%) and 154 (14.8%), re-
spectively, of 1044 men and women who attended clinics
in Boston, USA, which were equivalent to the findings of
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ences in the detection rates of M. genitalium, M. hominis,
and Ureaplasma spp. in males between the oral cavity and
urine samples, suggesting that genital Mycoplasma spp.
and Ureaplasma spp. could frequently infect the male oral
cavity.
It has been reported that the presence of infection in
the urinary tract is an independent risk factor for HPV
infection [15]. HPV generally infects the basal layer of
the mucosa, and inflammation and microinjury of the
urothelium caused by N. gonorrhoeae, C. trachomatis,
and/or M. genitalium are likely to facilitate access of
HPV to the basal cells of the urothelium in the urethra.
However, multivariate analysis indicated that oral gonococ-
cal infection was a negative factor for oral HPV infection
in the present study. One possible reason or this observa-
tion is that there were no patients with pharyngitis-like
symptoms. Most oropharyngeal gonococcal or chlamydial
infections are asymptomatic without inflammation of the
oropharynx [29], and it may not be possible to demonstrate
that other isolated microorganisms, such as N. gonor-
rhoeae, C. trachomatis, and M. genitalium, were risk fac-
tors for the detection of oral HPV infection. Alternatively,
the population size in the present study was small, and fur-
ther large-scale studies will be required to reach more de-
finitive conclusions.
In the present study, a liquid-based cytological proced-
ure, which is commonly used in cervical cancer screen-
ing, was used for detection of HPV in oropharyngeal
gargle and urine samples. Urine is generally considered
unsuitable for the detection of HPV due to the poor
β-globin detection rate (< 50%) [30]. However, our previ-
ous study indicated that the liquid-based cytological pro-
cedure is useful for HPV detection in urine samples from
men, and we found that the detection rate of the β-globin
gene was > 97% in urine from healthy men and male
patients with urethritis [25]. We found an excellent detec-
tion rate (100%) of β-globin in oropharyngeal gargle sam-
ples using a liquid-based cytological procedure, suggesting
that this method, which is recommended for testing oro-
pharyngeal STIs, such as N. gonorrhoeae, C. trachomatis,
Mycoplasma spp., and Ureaplasma spp., is also suitable for
detection of HPV in oropharyngeal gargle samples.Conclusion
In conclusion, oral HPV infection is common in sexually
active men, and its prevalence rate was equivalent to that
in urine samples. In addition, oral HPV infection was sig-
nificantly correlated with urinary HPV infection.
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